Drug-labels.com

NTP-Pramipexole: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Pre Market
Strength:
0.25 mg, 0.5 mg, 1.0 mg, 1.5 mg

Patient Medication Information: uses, side effects, how to take - NTP-Pramipexole

ABOUT THIS MEDICATION

What the medication is used for:

NTP-PRAMIPEXOLE is used to treat early and late stage Parkinson's disease. NTP-PRAMIPEXOLE provides relief of signs and symptoms of Parkinson's Disease. Sign and symptoms of the disease include: shaking (tremor), slowness in performing activities of daily living (bradykinesia), muscle stiffness (rigidity) and mood changes (depression). In late stage Parkinson's disease, NTP-PRAMIPEXOLE will be used in combination with levodopa.

What it does:

NTP-PRAMIPEXOLE belongs to a group of medicines known as “dopamine agonists”. NTP-PRAMIPEXOLE improves some of the chemical imbalance in the part of the brain affected by Parkinson's Disease.

When it should not be used:

If you are allergic to NTP-PRAMIPEXOLE, or any of the nonmedicinal ingredients of the product (see list below). NTP-PRAMIPEXOLE is not recommended for children under 18 years of age.

What the medicinal ingredient is:

pramipexole dihydrochloride monohydrate

What the important nonmedicinal ingredients are:

Colloidal silicon dioxide, lactose / maize starch, magnesium stearate, microcrystalline cellulose and sodium starch glycolate.

What dosage forms it comes in:

NTP-PRAMIPEXOLE (pramipexole dihydrochloride monohydrate) tablets are available in bottles of 90 tablets; tablets are 0.25 mg, 0.5 mg, 1.0 mg, and 1.5 mg.

WARNING AND PRECAUTIONS

You are warned of a sudden onset of sleep condition which may occur without warning, while taking NTP-PRAMIPEXOLE. You should not operate machinery or engage in activities that require alertness, as you may put yourself and others at risk of serious injury or death. This sudden onset of sleep condition has also been reported in patients taking other anti-Parkinson drugs of the same class.

Studies of people with Parkinson’s disease show that they may be at an increased risk of developing melanoma (a form of skin cancer) when compared to people without Parkinson’s disease. It is not known if this problem is associated with Parkinson’s disease or the drugs used to treat Parkinson’s disease. NTP-PRAMIPEXOLE is one of the drugs used to treat Parkinson’s disease; therefore, patients treated with NTP-PRAMIPEXOLE should have periodic skin examinations.

Patients and caregivers should be aware of the fact that abnormal behaviour such as pathological gambling, increased sexual desire, excessive sexual activity, compulsive shopping or binge eating have been reported. Those changes have also been reported in patients taking other anti-Parkinson drugs of the same class.

BEFORE you use NTP-PRAMIPEXOLE talk to your doctor or pharmacist:

  • if you have any health problems, especially kidney problems or blood pressure problems;
  • if you have any unusual conditions related to your eyes or eyesight;
  • if you have previously taken NTP-

    PRAMIPEXOLE and became unwell;

  • if you have any allergies or reactions to foods or drugs;
  • if you are pregnant or intend to become pregnant;

  • if you are breast feeding;
  • if you are taking any other medications, including any drugs you can buy without a prescription.
  • If you drive a vehicle or perform hazardous tasks during your work.

INTERACTIONS WITH THIS MEDICATION

Other medications may be affected by NTP-PRAMIPEXOLE or may affect how NTP-PRAMIPEXOLE works. Do not take any other medication, including over-the-counter medications or herbal products unless your doctor tells you to. Tell any other doctor, dentist or pharmacist that you talk to that you are taking NTP-PRAMIPEXOLE. Avoid alcohol or other sedatives while taking NTP-PRAMIPEXOLE.

PROPER USE OF THIS MEDICATION

Usual dose:

Parkinson’s disease

Take NTP-PRAMIPEXOLE in equal doses, three times daily as prescribed by your doctor. Dosages should be increased gradually from a starting dose of 0.125 mg three times daily and should not be increased more frequently than every 5 to 7 days. It is important that your doctor increases your dosage of NTP-PRAMIPEXOLE gradually to avoid side effects and to achieve the best therapeutic effect. Your dose will probably change each week until your doctor and you decide what the best dose is for you. Make sure that you only use the tablet strength that your doctor has prescribed. The maximal recommended dose of NTP-PRAMIPEXOLE is 4.5 mg per day. Lower doses are recommended for patients with kidney disease.

Your doctor may decide to lower your dose of levodopa to prevent excessive side effects and to make sure that you are getting the best results from both drugs. Pay close attention to your doctor's instructions and never change the dose of either drug yourself.

You should not change the dose or discontinue treatment with NTP-PRAMIPEXOLE without the recommendation of your doctor.

You may take NTP-PRAMIPEXOLE without food or with food if you find that you feel sick to your stomach while taking the tablets.

Overdose:

If you accidentally take too many tablets, you should get medical help immediately by calling your doctor, hospital emergency department or regional Poison Control Centre or by going to the nearest hospital (do not drive yourself). Always take the labelled medicine container with you whether or not there are any NTP-PRAMIPEXOLE tablets left.

Missed Dose:

If you forget to take a dose, take it as soon as you remember, then carry on as before. However, if it is almost time for your next dose, skip the dose you missed and take the next dose when you are supposed to. Do not take more than one dose at a time.

NTP-PRAMIPEXOLE has been prescribed for you. Do not give these tablets to anyone else, even if you think they have the same condition as you.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

You should be aware that prescription medicines carry some risks and that all possible risks may not be known at this stage. Discuss with your doctor the risks of taking NTP-PRAMIPEXOLE against the expected benefits.

  • NTP-PRAMIPEXOLE may cause unwanted effects such as nausea, constipation, sleepiness, dream abnormalities, amnesia, fatigue, muscle weakness, restlessness, weight decrease, visual disturbance, accidental injury and confusion.. If you do experience any unusual or unwanted effects while you are taking NTP-

    PRAMIPEXOLE, be sure to tell your doctor. It is important that he/she knows of any unwanted effects to determine the best dose of NTP-PRAMIPEXOLE for you.

  • NTP-PRAMIPEXOLE does not usually affect people’s normal activities. However, some people may feel dizzy or sleepy while taking NTP-PRAMIPEXOLE, especially during the first few weeks of treatment.
SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT
TO DO ABOUT THEM
Symptom /effectTalk with your doctor or pharmacistStop taking drug and call your doctor or pharmacist
Only if severeIn all cases
CommonDyskinesia (Difficulty performing voluntary movements)√

Hallucination s

(see, hear, smell,

taste or feel some-thing that is not there)

√
SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT
TO DO ABOUT THEM

Insomnia

(Difficulty falling asleep)

√

Low blood pressure with dizziness

when

rising to a

sitting

or standing position. You may feel sick, light-headed, faint or you may sweat

√
Uncommon

Behavioral changes such as

compulsive gambling, changes in sexual

desire or

increased

eating

√

Delusion (a false

belief, despite incontrovertib le

evidence, that something is false)

√

Paranoia (unrealistic and

excessive anxiety and worry)

√

Sudden onset of

sleep

√

Do not be alarmed by this list of possible side effects. You may not experience any of them. This is not a complete list of side effects. For any unexpected effects while taking NTP-PRAMIPEXOLE, contact your doctor or pharmacist immediately, so that these effects may be properly addressed.

HOW TO STORE IT

  • Keep this drug away from light and moisture.

    NTP-PRAMIPEXOLE may change colour when exposed to light.

    • NTP-PRAMIPEXOLE should be stored at room temperature (15 – 30oC) in the original container.
    • The expiry date of this medicine is printed on the label. Do not use the medicine after this date.
    • Keep this drug out of the reach of children.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

-----------------------------------------------------------------

$ Report online at

www.healthcanada.gc.ca/medeffect $ Call toll-free at 1-866-234-2345 $ Complete a Canada Vigilance Reporting

Form and:

  • Fax toll-free to 1-866-678-6789, or
  • Mail to: Canada Vigilance Program Health Canada

    Postal Locator 0701C Ottawa, ON K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals can be found by contacting NT Pharma Canada Ltd. at:

1-800-268-4127 ext. 5005 (English);

1-877-777-9117 (French)

or druginfo@tevacanada.com

NT Pharma Canada Limited

5691 Main Street

Stouffville, Ontario

Canada, L4A 1H5

Last revised: January 28, 2011

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02362287

Revision date stated in the text: January 28, 2011

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for NTP-Pramipexole

Rx or OTC
Prescription (Rx)?
DIN 02362287, 02362295, 02362309, 02362317
Schedule(s) PRESCRIPTION
Active ingredient(s) Pramipexole dihydrochloride monohydrate
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. N Nervous system drugs
    1. N04 Anti-parkinson drugs
      1. N04B Dopaminergic agents
        1. N04BC Dopamine agonists
          1. N04BC05 Pramipexole
Company NT PHARMA CANADA LTD
Current status Cancelled Pre Market
Current status date March 16, 2017
Strengths and forms
DIN Strength Dosage form(s) Current status
02362287 0.25 MG Tablet Cancelled Pre Market March 16, 2017
02362295 0.5 MG Tablet Cancelled Pre Market March 16, 2017
02362309 1.0 MG Tablet Cancelled Pre Market March 16, 2017
02362317 1.5 MG Tablet Cancelled Pre Market March 16, 2017

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.